COPD and smoking

Real world effects of COPD medications: a cohort study with validation against results from randomised controlled trials
Kevin Wing, Elizabeth Williamson, James R. Carpenter, Lesley Wise, Sebastian Schneeweiss, Liam Smeeth, Jennifer K. Quint, Ian Douglas

European Respiratory Journal Mar 2021, 57 (3) 2001586; DOI: 10.1183/13993003.01586-2020
Life-course socioeconomic disadvantage and lung function: a multicohort study of 70 496 individuals
Vânia Rocha, Sílvia Fraga, Carla Moreira, Cristian Carmeli, Alexandra Lenoir, Andrew Steptoe, Graham Giles, Marcel Goldberg, Marie Zins, Mika Kivimäki, Paolo Vineis, Peter Vollenweider, Henrique Barros, Silvia Stringhini

European Respiratory Journal Mar 2021, 57 (3) 2001600; DOI: 10.1183/13993003.01600-2020
Mechanisms of orthopnoea in patients with advanced COPD
Amany F. Elbehairy, Azmy Faisal, Hannah McIsaac, Nicolle J. Domnik, Kathryn M. Milne, Matthew D. James, J. Alberto Neder, Denis E. O'Donnell

European Respiratory Journal Mar 2021, 57 (3) 2000754; DOI: 10.1183/13993003.00754-2020
A high-risk airway mycobiome is associated with frequent exacerbation and mortality in COPD
Pei Yee Tiew, Alison J. Dicker, Holly R. Keir, Mau Ern Poh, Sze Lei Pang, Micheál Mac Aogáin, Branden Qi Yu Chua, Jiunn Liang Tan, Huiying Xu, Mariko Siyue Koh, Augustine Tee, John Arputhan Abisheganaden, Fook Tim Chew, Bruce E. Miller, Ruth Tal-Singer, James D. Chalmers, Sanjay H. Chotirmall

European Respiratory Journal Mar 2021, 57 (3) 2002050; DOI: 10.1183/13993003.02050-2020
Assessment of chronic bronchitis and risk factors in young adults: results from BAMSE
Gang Wang, Jenny Hallberg, Petra Um Bergström, Christer Janson, Göran Pershagen, Olena Gruzieva, Marianne van Hage, Antonios Georgelis, Anna Bergström, Inger Kull, Anders Lindén, Erik Melén

European Respiratory Journal Mar 2021, 57 (3) 2002120; DOI: 10.1183/13993003.02120-2020
Accelerated FEV₁ decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients
Hannah R. Whittaker, Chloe Bloom, Ann Morgan, Deborah Jarvis, Steven J. Kiddle, Jennifer K. Quint

European Respiratory Journal Mar 2021, 57 (3) 2000918; DOI: 10.1183/13993003.00918-2020
Osteoporosis and fracture risk associated with inhaled corticosteroid use among Swedish COPD patients: the ARCTIC study
Christer Janson, Karin Lisspers, Björn Ställberg, Gunnar Johansson, Florian S. Gutzwiller, Karen Mezzi, Linda Mindeholm, Bine Kjoeller Bjerregaard, Leif Jorgensen, Kjell Larsson

European Respiratory Journal Feb 2021, 57 (2) 2000515; DOI: 10.1183/13993003.00515-2020
Should the number of acute exacerbations in the previous year be used to guide treatments in COPD?
Mohsen Sadatsafavi, James McCormack, John Petkau, Larry D. Lynd, Tae Yoon Lee, Don D. Sin

European Respiratory Journal Feb 2021, 57 (2) 2002122; DOI: 10.1183/13993003.02122-2020
A prospective safety and feasibility study of metered cryospray for patients with chronic bronchitis in COPD
Justin L. Garner, Tawimas Shaipanich, Jorine E. Hartman, Christopher M. Orton, Cielito Caneja, Karin Klooster, John Thornton, Don D. Sin, Dirk-Jan Slebos, Pallav L. Shah

European Respiratory Journal Dec 2020, 56 (6) 2000556; DOI: 10.1183/13993003.00556-2020
The undiagnosed disease burden associated with alpha-1 antitrypsin deficiency genotypes
Tomoko Nakanishi, Vincenzo Forgetta, Tomohiro Handa, Toyohiro Hirai, Vincent Mooser, G. Mark Lathrop, William O.C.M. Cookson, J. Brent Richards

European Respiratory Journal Dec 2020, 56 (6) 2001441; DOI: 10.1183/13993003.01441-2020

Main menu

User menu

Search

COPD and smoking

Pages

Contact us